IP 212 IP 212 Pill - white purple capsule/oblong, 16mm
Pill with imprint IP 212 IP 212 is White / Purple, Capsule/Oblong and has been identified as Phenytoin Sodium Extended 100 mg. It is supplied by Amneal Pharmaceuticals.
Phenytoin is used in the treatment of Epilepsy; Seizures; Neurosurgery; Seizure Prophylaxis During or Following Neurosurgery; Status Epilepticus and belongs to the drug classes group I antiarrhythmics, hydantoin anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Phenytoin 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for IP 212 IP 212
Phenytoin Sodium Extended
- Imprint
- IP 212 IP 212
- Strength
- 100 mg
- Color
- White / Purple
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Group I antiarrhythmics, Hydantoin anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
65162-0212 | Amneal Pharmaceuticals LLC |
68084-0376 | Amerisource Health Services |
10135-0603 | Marlex Pharmaceuticals Inc. |
00904-6187 | Major Pharmaceuticals |
Related images for "IP 212 IP 212"
More about phenytoin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (112)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: group I antiarrhythmics
- Breastfeeding
Patient resources
- Phenytoin drug information
- Phenytoin injection
- Phenytoin (Injection) (Advanced Reading)
- Phenytoin (Oral) (Advanced Reading)
- Phenytoin Chewable Tablets
Other brands
Dilantin, Phenytek, Phenytoin Sodium, Prompt
Professional resources
- Phenytoin, Phenytoin Sodium monograph
- Phenytoin Capsules (FDA)
- Phenytoin Chewable Tablets (FDA)
- Phenytoin Infatabs (FDA)
- Phenytoin Oral Suspension (FDA)
Other brands
Dilantin, Phenytoin Sodium, Phenytek
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.